Back to School: How biopharma can reboot drug development. Access exclusive analysis here

R-albuterol: Began Phase II trial to compare bronchodilatory effect with racemic albuterol in 20 patients to be enrolled in the placebo-controlled, double-blind

Sepracor Inc. (SEPR), Marlborough,

Read the full 44 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE